Your browser doesn't support javascript.
loading
Bevacizumab, Pemetrexed, and Cisplatin, or Bevacizumab and Erlotinib for Patients With Advanced Non-Small-Cell Lung Cancer Stratified by Epidermal Growth Factor Receptor Mutation: Phase II Trial SAKK19/09.
Gautschi, Oliver; Mach, Nicholas; Rothschild, Sacha I; Li, Qiyu; Stahel, Rolf A; Zippelius, Alfred; Cathomas, Richard; Früh, Martin; Betticher, Daniel C; Peters, Solange; Rauch, Daniel; Feilchenfeldt, Jonas; Bubendorf, Lukas; Savic, Spasenija; Jaggi, Rolf; Leibundgut, Elisabeth Oppliger; Largiadèr, Carlo; Brutsche, Martin; Pilop, Christiane; Stalder, Lukas; Pless, Miklos; Ochsenbein, Adrian F.
Affiliation
  • Gautschi O; Medical Oncology, Cantonal Hospital Luzern, Luzern, Switzerland. Electronic address: oliver.gautschi@luks.ch.
  • Mach N; Clinical Research Unit of the Dr. Dubois-Ferrière Dinu Lipatti Foundation, Oncology Center, Geneva University Hospital, Geneva, Switzerland.
  • Rothschild SI; Medical Oncology, University Hospital Basel, Basel, Switzerland.
  • Li Q; SAKK Coordinating Center, Bern, Switzerland.
  • Stahel RA; Medical Oncology, University Hospital Zurich, Zurich, Switzerland.
  • Zippelius A; Medical Oncology, University Hospital Basel, Basel, Switzerland.
  • Cathomas R; Medical Oncology, Cantonal Hospital Graubünden, Chur, Switzerland.
  • Früh M; Medical Oncology, Cantonal Hospital St Gallen, St Gallen, Switzerland.
  • Betticher DC; Medical Oncology, Cantonal Hospital Fribourg, Fribourg, Switzerland.
  • Peters S; Cancer Center, University Hospital Lausanne, Lausanne, Switzerland.
  • Rauch D; Medical Oncology, Cantonal Hospital Thun, Thun, Switzerland.
  • Feilchenfeldt J; Medical Oncology, Cantonal Hospital Valais, Sion, Switzerland.
  • Bubendorf L; Institute of Pathology, University Hospital Basel, Basel, Switzerland.
  • Savic S; Institute of Pathology, University Hospital Basel, Basel, Switzerland.
  • Jaggi R; Department of Clinical Research, University of Bern, Bern, Switzerland.
  • Leibundgut EO; Department of Hematology, University Hospital Bern, Bern, Switzerland.
  • Largiadèr C; Laboratory of Clinical Chemistry, University Hospital Bern, Bern, Switzerland.
  • Brutsche M; Pulmonology, Cantonal Hospital St Gallen, St Gallen, Switzerland.
  • Pilop C; SAKK Coordinating Center, Bern, Switzerland.
  • Stalder L; SAKK Coordinating Center, Bern, Switzerland.
  • Pless M; Medical Oncology, Cantonal Hospital Winterthur, Winterthur, Switzerland.
  • Ochsenbein AF; Medical Oncology, University Hospital Bern, Bern, Switzerland.
Clin Lung Cancer ; 16(5): 358-65, 2015 Sep.
Article in En | MEDLINE | ID: mdl-25843489
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Non-Small-Cell Lung / ErbB Receptors / Lung Neoplasms Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Clin Lung Cancer Journal subject: NEOPLASIAS Year: 2015 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Non-Small-Cell Lung / ErbB Receptors / Lung Neoplasms Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Clin Lung Cancer Journal subject: NEOPLASIAS Year: 2015 Document type: Article Country of publication: United States